0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Intranasal Corticosteroids Market Research Report 2024
Published Date: March 2024
|
Report Code: QYRE-Auto-25X2634
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Intranasal Corticosteroids Market Insights and Forecast to 2028
BUY CHAPTERS

Global Intranasal Corticosteroids Market Research Report 2024

Code: QYRE-Auto-25X2634
Report
March 2024
Pages:74
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Intranasal Corticosteroids Market

Intranasal corticosteroids are the only potent and effective drugs which are used to treat various nasal complications such as nasal-polyps, nasal-rhinitis and chronic sinusitis.
The global Intranasal Corticosteroids market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Intranasal Corticosteroids is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Intranasal Corticosteroids is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Intranasal Corticosteroids in Hospital Pharmacies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Intranasal Corticosteroids include GlaxoSmithKline, Merck, Sanofi, SUMITOMO, Teva, Johnson & Johnson and AstraZeneca, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Intranasal Corticosteroids, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intranasal Corticosteroids.

Report Scope

The Intranasal Corticosteroids market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intranasal Corticosteroids market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intranasal Corticosteroids companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Intranasal Corticosteroids Market Report

Report Metric Details
Report Name Intranasal Corticosteroids Market
Segment by Type
  • Prescribed Drugs
  • OTC Drugs
Segment by Application
  • Hospital Pharmacies
  • Online Pharnacies
  • Retail Pharmacies
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GlaxoSmithKline, Merck, Sanofi, SUMITOMO, Teva, Johnson & Johnson, AstraZeneca
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Intranasal Corticosteroids companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Intranasal Corticosteroids Market report?

Ans: The main players in the Intranasal Corticosteroids Market are GlaxoSmithKline, Merck, Sanofi, SUMITOMO, Teva, Johnson & Johnson, AstraZeneca

What are the Application segmentation covered in the Intranasal Corticosteroids Market report?

Ans: The Applications covered in the Intranasal Corticosteroids Market report are Hospital Pharmacies, Online Pharnacies, Retail Pharmacies

What are the Type segmentation covered in the Intranasal Corticosteroids Market report?

Ans: The Types covered in the Intranasal Corticosteroids Market report are Prescribed Drugs, OTC Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Intranasal Corticosteroids Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Prescribed Drugs
1.2.3 OTC Drugs
1.3 Market by Application
1.3.1 Global Intranasal Corticosteroids Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Online Pharnacies
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Intranasal Corticosteroids Market Perspective (2019-2030)
2.2 Intranasal Corticosteroids Growth Trends by Region
2.2.1 Global Intranasal Corticosteroids Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Intranasal Corticosteroids Historic Market Size by Region (2019-2024)
2.2.3 Intranasal Corticosteroids Forecasted Market Size by Region (2025-2030)
2.3 Intranasal Corticosteroids Market Dynamics
2.3.1 Intranasal Corticosteroids Industry Trends
2.3.2 Intranasal Corticosteroids Market Drivers
2.3.3 Intranasal Corticosteroids Market Challenges
2.3.4 Intranasal Corticosteroids Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Intranasal Corticosteroids Players by Revenue
3.1.1 Global Top Intranasal Corticosteroids Players by Revenue (2019-2024)
3.1.2 Global Intranasal Corticosteroids Revenue Market Share by Players (2019-2024)
3.2 Global Intranasal Corticosteroids Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Intranasal Corticosteroids Revenue
3.4 Global Intranasal Corticosteroids Market Concentration Ratio
3.4.1 Global Intranasal Corticosteroids Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Intranasal Corticosteroids Revenue in 2023
3.5 Intranasal Corticosteroids Key Players Head office and Area Served
3.6 Key Players Intranasal Corticosteroids Product Solution and Service
3.7 Date of Enter into Intranasal Corticosteroids Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Intranasal Corticosteroids Breakdown Data by Type
4.1 Global Intranasal Corticosteroids Historic Market Size by Type (2019-2024)
4.2 Global Intranasal Corticosteroids Forecasted Market Size by Type (2025-2030)
5 Intranasal Corticosteroids Breakdown Data by Application
5.1 Global Intranasal Corticosteroids Historic Market Size by Application (2019-2024)
5.2 Global Intranasal Corticosteroids Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Intranasal Corticosteroids Market Size (2019-2030)
6.2 North America Intranasal Corticosteroids Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Intranasal Corticosteroids Market Size by Country (2019-2024)
6.4 North America Intranasal Corticosteroids Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Intranasal Corticosteroids Market Size (2019-2030)
7.2 Europe Intranasal Corticosteroids Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Intranasal Corticosteroids Market Size by Country (2019-2024)
7.4 Europe Intranasal Corticosteroids Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Intranasal Corticosteroids Market Size (2019-2030)
8.2 Asia-Pacific Intranasal Corticosteroids Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Intranasal Corticosteroids Market Size by Region (2019-2024)
8.4 Asia-Pacific Intranasal Corticosteroids Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Intranasal Corticosteroids Market Size (2019-2030)
9.2 Latin America Intranasal Corticosteroids Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Intranasal Corticosteroids Market Size by Country (2019-2024)
9.4 Latin America Intranasal Corticosteroids Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Intranasal Corticosteroids Market Size (2019-2030)
10.2 Middle East & Africa Intranasal Corticosteroids Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Intranasal Corticosteroids Market Size by Country (2019-2024)
10.4 Middle East & Africa Intranasal Corticosteroids Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Detail
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Intranasal Corticosteroids Introduction
11.1.4 GlaxoSmithKline Revenue in Intranasal Corticosteroids Business (2019-2024)
11.1.5 GlaxoSmithKline Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Intranasal Corticosteroids Introduction
11.2.4 Merck Revenue in Intranasal Corticosteroids Business (2019-2024)
11.2.5 Merck Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Detail
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Intranasal Corticosteroids Introduction
11.3.4 Sanofi Revenue in Intranasal Corticosteroids Business (2019-2024)
11.3.5 Sanofi Recent Development
11.4 SUMITOMO
11.4.1 SUMITOMO Company Detail
11.4.2 SUMITOMO Business Overview
11.4.3 SUMITOMO Intranasal Corticosteroids Introduction
11.4.4 SUMITOMO Revenue in Intranasal Corticosteroids Business (2019-2024)
11.4.5 SUMITOMO Recent Development
11.5 Teva
11.5.1 Teva Company Detail
11.5.2 Teva Business Overview
11.5.3 Teva Intranasal Corticosteroids Introduction
11.5.4 Teva Revenue in Intranasal Corticosteroids Business (2019-2024)
11.5.5 Teva Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Intranasal Corticosteroids Introduction
11.6.4 Johnson & Johnson Revenue in Intranasal Corticosteroids Business (2019-2024)
11.6.5 Johnson & Johnson Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Detail
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Intranasal Corticosteroids Introduction
11.7.4 AstraZeneca Revenue in Intranasal Corticosteroids Business (2019-2024)
11.7.5 AstraZeneca Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Intranasal Corticosteroids Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Prescribed Drugs
    Table 3. Key Players of OTC Drugs
    Table 4. Global Intranasal Corticosteroids Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 5. Global Intranasal Corticosteroids Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Intranasal Corticosteroids Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Intranasal Corticosteroids Market Share by Region (2019-2024)
    Table 8. Global Intranasal Corticosteroids Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Intranasal Corticosteroids Market Share by Region (2025-2030)
    Table 10. Intranasal Corticosteroids Market Trends
    Table 11. Intranasal Corticosteroids Market Drivers
    Table 12. Intranasal Corticosteroids Market Challenges
    Table 13. Intranasal Corticosteroids Market Restraints
    Table 14. Global Intranasal Corticosteroids Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Intranasal Corticosteroids Market Share by Players (2019-2024)
    Table 16. Global Top Intranasal Corticosteroids Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intranasal Corticosteroids as of 2023)
    Table 17. Ranking of Global Top Intranasal Corticosteroids Companies by Revenue (US$ Million) in 2023
    Table 18. Global 5 Largest Players Market Share by Intranasal Corticosteroids Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Intranasal Corticosteroids Product Solution and Service
    Table 21. Date of Enter into Intranasal Corticosteroids Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Intranasal Corticosteroids Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Intranasal Corticosteroids Revenue Market Share by Type (2019-2024)
    Table 25. Global Intranasal Corticosteroids Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Intranasal Corticosteroids Revenue Market Share by Type (2025-2030)
    Table 27. Global Intranasal Corticosteroids Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Intranasal Corticosteroids Revenue Market Share by Application (2019-2024)
    Table 29. Global Intranasal Corticosteroids Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Intranasal Corticosteroids Revenue Market Share by Application (2025-2030)
    Table 31. North America Intranasal Corticosteroids Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 32. North America Intranasal Corticosteroids Market Size by Country (2019-2024) & (US$ Million)
    Table 33. North America Intranasal Corticosteroids Market Size by Country (2025-2030) & (US$ Million)
    Table 34. Europe Intranasal Corticosteroids Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. Europe Intranasal Corticosteroids Market Size by Country (2019-2024) & (US$ Million)
    Table 36. Europe Intranasal Corticosteroids Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Asia-Pacific Intranasal Corticosteroids Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Asia-Pacific Intranasal Corticosteroids Market Size by Region (2019-2024) & (US$ Million)
    Table 39. Asia-Pacific Intranasal Corticosteroids Market Size by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Intranasal Corticosteroids Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Latin America Intranasal Corticosteroids Market Size by Country (2019-2024) & (US$ Million)
    Table 42. Latin America Intranasal Corticosteroids Market Size by Country (2025-2030) & (US$ Million)
    Table 43. Middle East & Africa Intranasal Corticosteroids Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Middle East & Africa Intranasal Corticosteroids Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Middle East & Africa Intranasal Corticosteroids Market Size by Country (2025-2030) & (US$ Million)
    Table 46. GlaxoSmithKline Company Detail
    Table 47. GlaxoSmithKline Business Overview
    Table 48. GlaxoSmithKline Intranasal Corticosteroids Product
    Table 49. GlaxoSmithKline Revenue in Intranasal Corticosteroids Business (2019-2024) & (US$ Million)
    Table 50. GlaxoSmithKline Recent Development
    Table 51. Merck Company Detail
    Table 52. Merck Business Overview
    Table 53. Merck Intranasal Corticosteroids Product
    Table 54. Merck Revenue in Intranasal Corticosteroids Business (2019-2024) & (US$ Million)
    Table 55. Merck Recent Development
    Table 56. Sanofi Company Detail
    Table 57. Sanofi Business Overview
    Table 58. Sanofi Intranasal Corticosteroids Product
    Table 59. Sanofi Revenue in Intranasal Corticosteroids Business (2019-2024) & (US$ Million)
    Table 60. Sanofi Recent Development
    Table 61. SUMITOMO Company Detail
    Table 62. SUMITOMO Business Overview
    Table 63. SUMITOMO Intranasal Corticosteroids Product
    Table 64. SUMITOMO Revenue in Intranasal Corticosteroids Business (2019-2024) & (US$ Million)
    Table 65. SUMITOMO Recent Development
    Table 66. Teva Company Detail
    Table 67. Teva Business Overview
    Table 68. Teva Intranasal Corticosteroids Product
    Table 69. Teva Revenue in Intranasal Corticosteroids Business (2019-2024) & (US$ Million)
    Table 70. Teva Recent Development
    Table 71. Johnson & Johnson Company Detail
    Table 72. Johnson & Johnson Business Overview
    Table 73. Johnson & Johnson Intranasal Corticosteroids Product
    Table 74. Johnson & Johnson Revenue in Intranasal Corticosteroids Business (2019-2024) & (US$ Million)
    Table 75. Johnson & Johnson Recent Development
    Table 76. AstraZeneca Company Detail
    Table 77. AstraZeneca Business Overview
    Table 78. AstraZeneca Intranasal Corticosteroids Product
    Table 79. AstraZeneca Revenue in Intranasal Corticosteroids Business (2019-2024) & (US$ Million)
    Table 80. AstraZeneca Recent Development
    Table 81. Research Programs/Design for This Report
    Table 82. Key Data Information from Secondary Sources
    Table 83. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Intranasal Corticosteroids Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Intranasal Corticosteroids Market Share by Type: 2023 VS 2030
    Figure 3. Prescribed Drugs Features
    Figure 4. OTC Drugs Features
    Figure 5. Global Intranasal Corticosteroids Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 6. Global Intranasal Corticosteroids Market Share by Application: 2023 VS 2030
    Figure 7. Hospital Pharmacies Case Studies
    Figure 8. Online Pharnacies Case Studies
    Figure 9. Retail Pharmacies Case Studies
    Figure 10. Intranasal Corticosteroids Report Years Considered
    Figure 11. Global Intranasal Corticosteroids Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 12. Global Intranasal Corticosteroids Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Intranasal Corticosteroids Market Share by Region: 2023 VS 2030
    Figure 14. Global Intranasal Corticosteroids Market Share by Players in 2023
    Figure 15. Global Top Intranasal Corticosteroids Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intranasal Corticosteroids as of 2023)
    Figure 16. The Top 10 and 5 Players Market Share by Intranasal Corticosteroids Revenue in 2023
    Figure 17. North America Intranasal Corticosteroids Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 18. North America Intranasal Corticosteroids Market Share by Country (2019-2030)
    Figure 19. United States Intranasal Corticosteroids Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. Canada Intranasal Corticosteroids Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Europe Intranasal Corticosteroids Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Europe Intranasal Corticosteroids Market Share by Country (2019-2030)
    Figure 23. Germany Intranasal Corticosteroids Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. France Intranasal Corticosteroids Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. U.K. Intranasal Corticosteroids Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Italy Intranasal Corticosteroids Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Russia Intranasal Corticosteroids Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Nordic Countries Intranasal Corticosteroids Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Asia-Pacific Intranasal Corticosteroids Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Asia-Pacific Intranasal Corticosteroids Market Share by Region (2019-2030)
    Figure 31. China Intranasal Corticosteroids Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Japan Intranasal Corticosteroids Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. South Korea Intranasal Corticosteroids Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Southeast Asia Intranasal Corticosteroids Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. India Intranasal Corticosteroids Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Australia Intranasal Corticosteroids Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Latin America Intranasal Corticosteroids Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Latin America Intranasal Corticosteroids Market Share by Country (2019-2030)
    Figure 39. Mexico Intranasal Corticosteroids Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Brazil Intranasal Corticosteroids Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Middle East & Africa Intranasal Corticosteroids Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Middle East & Africa Intranasal Corticosteroids Market Share by Country (2019-2030)
    Figure 43. Turkey Intranasal Corticosteroids Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Saudi Arabia Intranasal Corticosteroids Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. GlaxoSmithKline Revenue Growth Rate in Intranasal Corticosteroids Business (2019-2024)
    Figure 46. Merck Revenue Growth Rate in Intranasal Corticosteroids Business (2019-2024)
    Figure 47. Sanofi Revenue Growth Rate in Intranasal Corticosteroids Business (2019-2024)
    Figure 48. SUMITOMO Revenue Growth Rate in Intranasal Corticosteroids Business (2019-2024)
    Figure 49. Teva Revenue Growth Rate in Intranasal Corticosteroids Business (2019-2024)
    Figure 50. Johnson & Johnson Revenue Growth Rate in Intranasal Corticosteroids Business (2019-2024)
    Figure 51. AstraZeneca Revenue Growth Rate in Intranasal Corticosteroids Business (2019-2024)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS